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Abstract
Background: The polymorphism COMTval158met has been associated with suicidal behavior in case-control and
meta-analysis studies, but results and conclusions remain controversial. The objective of this study was to examine
the association between COMT val158met with suicidal behavior in a case-control study and to assess the
combined evidence -this case-control study and available data from other related studies- we carried out a meta-
analysis.
Methods: We conducted a case-control study with 105 patients with suicide attempts and 236 controls.
Subsequently, we performed a meta-analysis of published genetic association studies by searching through
Medline, PubMed and Web of Science databases.
Results: No significant differences were found in the distribution of alleles (c2 = 0.33, 1 df, p = 0.56) or genotypes
(c2 = 2.36, 2 df, p = 0.26). The meta-analysis comprising 12 association studies (including the present one) showed
that the risk COMTmet allele of COMTval158/met is not associated with suicidal behavior (OR: 1.09, 95% CI: 0.97-
1.23), even in the absence of heterogeneity (OR: 1.09, 95% CI: 0.97-1.23).
Conclusion: Our results showed no association between COMTval158/met and suicidal behavior. However, more
studies are necessary to determine conclusively an association between COMT and suicidal behavior.
Background
Suicidal behavior is a major health problem worldwide.
Suicide has been suggested to involve catecholaminergic
dysfunction and to have a genetic correlate. Many signif-
icant abnormalities in catecholaminergic dysfunction
have been identified in suicide attempters and comple-
ters [1]. For example, high concentration of noradrena-
line with decreased a2-adrenergic binding has been
described in the prefrontal cortex of suicide victims [2],
whereas low concentration of 3-methoxy-4-hydroxyphe-
nyglycol, a metabolite of norepinephrine, has been
observed in subjects who attempted suicide [3-5].
Several lines of evidence suggest that suicide has a
genetic component [6]. Attempted and completed
suicide show familial behavior. Family studies have
found that those patients more likely to display suicidal
behavior have parents with a history of suicidal beha-
vioral with a heritability of about 40-50% [7-11]. A large
number of studies in twins has also been reported. The
pooled data from seven twin studies report concordance
rates for suicide or suicide attempt of 23.5% in monozy-
gotic twin pairs and 0.13% in dizygotic twins [12-14].
Furthermore, the classic adoption studies demonstrate
higher suicide rates in the biological parents than in
adoptive parents of adoptees who died by suicide
[13,15]. Despite the large amount of studies conducted,
the specific genes that contribute to vulnerability for
suicidal behavior are unknown. One candidate gene in
the study of suicidal behavior is the gene encoding the
enzyme catechol-o-methyl-transferase (COMT). The
biological functions of COMT make it an attractive can-
didate gene for suicidal behavior. COMT is a major
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ters in the brain.
The COMT gene is located on the long arm of chro-
mosome 22 at 22q11; it spans 28 kb and contains six
exons. A common polymorphism of the COMT gene is
the val108/158met variant (rs4680). This polymorphism
is due to a G to A transition at codon 158 of the mem-
brane bound form of COMT, which corresponds to
codon 108 of the soluble form of COMT, resulting in a
valine (val) to methionine (met) substitution [16,17].
COMT is one of the enzymes that degrade catechola-
mines, including dopamine [16,17]. The low activity
COMT genotype (COMTmet/met), consisting of a met/
met allele pair, yields a 3-4 fold lower enzyme activity
compared to the high activity genotype (COMTval/val),
which has a val/val allele pair, whereas the COMTval/
met genotype produces intermediate enzyme activity
[18].
To date, the polymorphism rs4680 of COMT has been
associated with a number of disorders including schizo-
phrenia [19], bipolar disorder [20], major depressive dis-
order [21], obsessive compulsive disorder [22], and
Parkinson’s disease [23]. Several studies have investi-
gated the association between rs4680 of COMT and sui-
cidal behavior. Other COMT polymorphisms that have
been investigated are rs362204 and 2097603 [24]. Actu-
ally more than fourteen case-control studies have been
r e p o r t e d ,a sw e l la so n es t u d yi nt r i o s[ 2 5 ] .H o w e v e r ,
the association of COMT with suicidal behavior remains
controversial. In addition, two meta-analyses have been
published to date [11,26]. To explore the possibility that
some of these COMT variants have susceptibility for
suicidal behavior, we conducted a case-control study in
a Mexican population and then we used the combined
evidence to perform a meta-analysis of all the published
data.
Methods
Case-control study
Samples
A total of 105 patients were consecutively recruited
from the outpatient service of the General Hospital of
Comalcalco in the state of Tabasco, Mexico and from
the National Institute of Psychiatry Ramón de la Fuente
in Mexico City. These patients had attempted suicide
between January and August 2010. In addition, 236
unrelated controls were recruited for this study. All sub-
jects signed an informed consent to participate in the
study after they were given a verbal and written expla-
nation of the research objectives. To reduce ethnic var-
iation and stratification effects, only Mexican subjects
descending from Mexican parents and grandparents par-
ticipated in this study. The study was approved by the
local ethics committee and performed in accordance
with the ethics standards laid down in the 1975 Declara-
tion of Helsinki.
Clinical evaluation
DSM-IV Axis-I and II diagnoses were made using the
Structured Clinical Interview for DSM-IV in Spanish.
All patients were evaluated by a trained psychiatrist or
clinical psychologists with at least a master’s level
degree. Following the reports in the literature, we
defined a suicide attempt as a self-harm behavior with
at least some intent to end one’s life. Subjects were
excluded when the self-injury behaviors were deter-
mined to have no suicidal intention or ideation [5].
A total of 105 patients (55 males, 50 females) were
included in the study. Their mean age was 30.5 (11.40)
years old (range: 14-59 years). DSM-IV main lifetime
diagnoses of mental disorders among the patients were
as follows: schizophrenia spectrum disorders (n = 50),
anxiety disorders (n = 35), and undiagnosed (n = 20).
The mean number of suicide attempts was 2.06. The
possibility of childhood abuse sufferers was not
evaluated.
Control subjects consisted of 236 volunteers (132
males, 104 females); their mean age was 34.5 (10.1)
years old (range: 14-51 years). They were recruited from
the Blood Donor Center of the General Hospital of
Comalcalco and from the general population of the
Comalcalco city area in the state of Tabasco, México.
Subjects were physically healthy on medical evaluation.
All were of Mexican descent and none manifested psy-
chiatric problems, as assessed in brief interviews by psy-
chiatrists. Informed consent was obtained from each
control subject.
COMT val108/158met (rs4680) genotyping
Genomic DNA was extracted from peripheral blood leu-
kocytes using a modified version of the protocol by
Lahiri [27]. The final volume of the PCR reaction was 5
μLa n dc o n s i s t e do f2 0n gg e n o m i cD N A ,2 . 5F LT a q -
Man Master Mix, and 0.125 FL 20× Assay made to
order. The amplification was performed in 96-well plates
using the TaqMan Universal Thermal Cycling Protocol.
After the PCR end-point was reached, fluorescence
intensity was measured with the 7500 real-time PCR
system using SDS v2.1 software (Applied Biosystems).
An allelic discrimination was performed resulting in the
clear identification of three genotypes for COMT
Val108/158Met polymorphism. All genotyping was per-
formed blind to patient outcome. As a quality control in
our genotyping analyses we used random blind
duplicates.
Statistical Analysis
Hardy-Weinberg equilibrium was tested using Pearson’s
goodness-of-fit chi-squared test. Chi-squared test or
Fisher’s Exact test was used to compare genotype and
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associations given the sample size was analyzed using
the Quanto 1.2 software. The power of the analysis was
0.31. The level of significance was set at 0.05.
Meta-analysis study
Identification and selection of publications
A literature search comprising from January to March
2011 was performed. The publications were identified
using the following search terms in Medline, PubMed
and Web of Science databases: “COMT and suicidal
behavior”, “COMT and suicide”, rs4680 and suicidal
behavior”, rs4680 and suicide” and “COMT Val/Met
and suicide”.T h e s ew o r d sw e r ec o m b i n e dt or e t r i e v e
the summaries. The search also implicated the review of
the bibliography cited at the end of various research
articles to identify additional papers not covered by the
electronic search of abstracts.
To be selected, the publications had to fulfill the fol-
lowing criteria: (1) to be published in peer-reviewed
journals, (2) to be written in English, (3) to contain
independent data, (4) to be case-control association stu-
dies in which the frequencies of three genotypes were
clearly stated or could be calculated, and (5) the use of
healthy individuals as controls. Besides, we included one
article consisting only of cases, because the n in this
s t u d yw a sl a r g ea n dr a i s e dt h ed e t e c t i o np o w e ri nt h e
meta-analysis study [28].
Data Extraction
The following data were obtained for each of the stu-
dies: authors, year of publication, region, number of
cases and controls, number of alleles, male percentage,
diagnostic status, and association results. These data
were not always available for all studies. In cases of
missing data, we contacted the respective authors to ask
for the allele frequencies that were not included in the
main text of the papers. One of the studies did not
include a control group [29], but we made an adjust-
ment accordingly based on the other studies in the lit-
erature that included a control group [26]. Briefly, we
calculated the weighted frequency for a particular geno-
type from studies that included controls and applied it
to the study not including a control group. We consid-
ered the number of the “virtual” control group equal to
the number of patients in a specific study. Then the
hypothetical number of subjects with the particular gen-
otype frequency was assigned in proportion to the per-
centage of the same genotype which was obtained from
the weighted analysis [30].
The outcomes of the meta-analysis were built by tak-
ing into consideration the following categories: a)
exposed sick, b) exposed not-sick, c) not-exposed sick,
and d) not-exposed not-sick. The “sick” term refers to
subjects exhibiting suicidal behavior and the “exposed”
term to the allele of risk (COMTmet158).
Data analysis
For the meta-analysis procedures, we used the EPIDAT
3.1 program http://dxsp.sergas.es. This software is freely
available for epidemiologic analysis of tabulated data.
Data was analyzed with the random-effects model fol-
lowing the reports in the literature [31,32]. Sample het-
erogeneity was analyzed with the Dersimonian and
Laird’s Q test. The result of the Q test was complemen-
ted with graphs to help visualize those studies that
favored heterogeneity. The results of the meta-analysis
are expressed as an odds ratio (OR). To address the pro-
blem of publication bias, funnel plots were calculated by
the EPIDAT 3.1 software. This plotting standardizes the
effect of each of the published studies on the vertical
axis and its corresponding precision on the horizontal
axis. Likewise, we used the Egger’s test to complement
the funnel plots; the Egger’s test evaluates the hypoth-
esis of absence of bias of a publication. Finally, a chi-
squared (c2) analysis was used to calculate the Hardy-
Weinberg equilibrium to evaluate genotype distribution.
Results
Case-control study
Of the 105 suicide attempt patients, 34 (32.4%) had the
COMTval/val genotype, 58 (55.2%) the COMTval/met,
and 13 (12.4%) the COMTmet/met type. Genotype fre-
quencies in the patient group satisfied the Hardy-Wein-
berg equilibrium (p = 0.12). In the control group, 80
individuals (33.2) presented the COMTval/val genotype,
112 (47.6%) the COMTval/met type, and 44(15.7%) the
COMTmet/met type. No significant differences in geno-
type (c2 = 2.36, df = 2, p = 0.26) or allele (c2 = 0.33, df
= 1, p = 0.56) frequencies were observed between
patients and the control group.
Meta-analysis study
With regard to the literature search, a total of 18 papers
were identified, but only 12 were included in this meta-
analysis, including our case-control study [1,5,29,33-40]
(Table 1). The six excluded studies did not comply with
the inclusion criteria: in two of these studies genotype
frequencies could not be obtained [24,25]; other study
was carried out in families [41]; in other report the sam-
ple overlapped with a previous one [26]; the fifth was a
meta-analysis [11], and the sixth a review [42].
The selected studies comprised a total of 2723 cases
and 1886 controls. Our meta-analysis consisted of 2723
cases, 1399 more than the last meta-analysis reported in
the literature [26]. We observed that in all genotyped
populations, both patients and controls were in Hardy-
Weinberg equilibrium (p > 0.05), excluding the controls
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explored all populations in a combined way and we still
encountered them in equilibrium (p = 0.17, and p =
0.46, respectively).
Figure 1 shows the pooled OR derived from all studies
indicating a non-significant association of allele met in the
COMTval/met polymorphism with suicidal behavior
(Random effects model: OR: 1.07; 95% CI 0.85-1.33; p(Z) =
0.19). We observed heterogeneity in all studies (Q = 57.08,
df = 1; p = 0.0005). The Egger’s test indicated no evidence
of publication bias (t = 1.31, df = 10; p = 0.21) (Figure 2).
Therefore, we carried out a second analysis, which only
included studies inside the heterogeneity curve (Nedic [33],
Ono [1], Baud [36] and Nolan [37] reports were excluded).
Table 1 Descriptive characteristics of 13 studies on the role of COMT val158/met polymorphism in suicidal behavior
Study Sample
Size n
(cases-
control)
Location Diagnosis Number of Met alleles in
cases
Gender (Male/
female)
Mean Age
Cases Control Cases Control
Ohara 1998
[40]
12-135 Japanese Suicide Attempt 13
Russ 2000 [34] 51-51 Caucasians Suicide Ideation 46 32/19 28/23 38.1 41
Nolan 2000
[37]
84-64 US and Finnish Suicide Attempt 77 59/15 48/16 32 41
Liou 2001 [39] 62-188 Chinese, Asiatic Suicide Attempt 29 26/36 97/91 36.7 38.6
Rujescu 2003
[38]
328-149 German, Caucasian Suicide Attempt 159 53/96 149/
179
38.6 40
Ono 2004 [1] 163-169 Japanese, Asiatic Completed Suicide 111 112/
51
114/55 46.4
Baud 2007 [36] 427-185 Switzerland and
France
Suicide Attempt 388 46.0 38.7
Zalsman 2008
[35]
201-119 Caucasian-
European
Suicide Attempt 220 41.6 41.2
Perroud 2010
[29]
875 France and
Switzerland
Suicide Attempt 784 256/
619
39.6
Lee 2011 [5] 197-170 Korean Suicide Attempt 121 70/
127
85/85 49.3 50.7
Nedic 2011
[33]
82-311 Croatian,
Caucasians
Alcohol Dependence, Suicide
Attempt
108 59/23 255/58 50.46 50.70
Tovilla-Zárate
2011
105-236 Mexican Suicide Attempt 84 55/50 132/
104
30.5 34.5
Figure 1 Odds ratios for the met allele of the val/158met polymorphism in the COMT gene of individuals with suicidal behavioral.
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95% CI: 0.97-1.23; Z: 1.11, P(Z) = 0.26) (Table 2).
In addition, when we included an explorative analysis
of each of the Caucasian samples, significant heteroge-
neity was encountered (Q = 26.5; df = 5; p = 0.0001).
Nedic [33] and Baud [36] reports contributed to the het-
erogeneity. Also, we could not detect a significant asso-
ciation between COMTmet allele and suicidal behavior
(OR: 1.10; 95% CI: 0.91-1.16; p(Z) = 0.25).
Finally, we selected a subgroup of the whole sample
and performed an analysis of the studies containing only
suicide attempters; however, the result was also negative
(OR = 1.09, 95% CI: 0.96-1.22; Z = 0.60, P(Z) = 0.54).
The same occurred without the presence of heterogene-
ity (Q = 6.07, df = 6, p = 0.41) (Figure 3).
Discussion
In this study, we explored the association of COMTval/
met (rs4680) with suicidal behavior. First a case-control
study was conducted. Additionally, we performed a
meta-analysis to assess the evidence of association
between COMTval/met and suicidal behavior.
We could not find any association between COMT-
met or COMTval allele and suicidal behavioral in a
Mexican population. To our knowledge, this is the first
study addressing the genetic association between
COMTval/met alleles and suicidal behavior in a Mexi-
can population. Our results are in agreement with
recent reports in the literature stating the no association
of COMTval/met and suicidal behavior [26,35]. This
result is not surprising considering that complex beha-
viors, such as suicidal behavior, are the result of a mod-
erate number of genes that individually have small to
modest effects on disease liability [26,43].
Available evidence suggests that the effect of this
polymorphism on suicidal behavior may be related to
the lethality of suicide attempts rather than to the
risk for attempting suicide per se [11,35]. In our
s t u d yw eo n l yp e r f o r m e dan association with
attempted suicide, because we wanted to establish
which COMT polymorphisms were associated with
suicide attempts; this could be considered as a limita-
tion of our study. However, other study analyzing
genotype differences with respect to lethality of sui-
cide attempts or violent attempt methods reported
results similar to ours [35].
It is worth mentioning the evidence provided by other
studies reporting a positive association of the COMTval
allele when compared to the control group [5,36-38].
But these results are controversial, since such associa-
tion was observed in presence of the COMTmet allele
in patients presenting alcohol dependency or other dis-
eases [33]. These differences among studies might be
explained by the different diagnostic entities used. Some
studies evaluated patients with alcohol dependence,
while others included patients with schizophrenia, or
schizoaffective or mood disorders [33]. Other limitation
could be that these association studies were conducted
in various populations and different criteria were used
to define the phenotypes. Other relevant factor is the
Figure 2 Funnel plot indicating publication bias.
Table 2 Meta-analysis of case-control studies on the role of the COMT (catechol-O-methyltrasferase) val158/108Met
polymorphism in suicidal behavior
References Number of COMTval alleles Number of COMTmet alleles Odds Ratio (95% IC)
Cases Control Cases Control
Tovilla-Zárate 126 272 84 200 0.90 (0.65-1.26)
Lee [5] 223 273 117 121 1.18 (0.86-1.61)
Perroud [29] 848 255 784 221 1.06 (0.86-1.30)
Zalsman [35] 182 121 220 117 1.25 (0.90-1.72)
Rujescu [38] 139 323 159 333 1.10 (0.84-1.95)
Liou [39] 95 275 29 101 0.83 (0.51-1.33)
Russ [34] 52 58 46 40 1.28 (0.72-2.25)
Ohara [40] 11 175 13 95 2.17 (0.93-5.04)
Random effects 1676 1752 1452 1228 1.09 (0.97-1.23)
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almost all studies consisted of small samples (n < 200)
and some even made subdivisions within samples (gen-
der or affective status, for example). Hence, n was very
small and had a low power of association. When we
detected this limitation we decided to analyze the evi-
dence in a meta-analysis.
We tested the probability of the association of
COMTmet with suicidal behavior. However, we could
not find any association between these two factors. A
previous meta-analysis reported a Met association with
suicidal behavior [11]; however, this association is not
strong because the results of this meta-analysis were
highly dependent upon the inclusion of all the studies.
When five of the six studies involved were individually
removed from the analysis, the relationship between
COMT and suicidal behavior was no longer significant
[11]. Our results are in accordance with other recently
published meta-analysis in which no association was
found between Met or Val allele and suicidal behavior
[26]. This evidence supports a lack of direct modulation
of COMT on suicidal behavior.
Similarly to the results presented in a previous study,
the sample sizes of the studies included in the present
meta-analysis are in the low range compared to genetics
studies for other diseases. Therefore, future studies com-
prising larger samples of completed suicide are impor-
tant to determine this association. We also consider that
given the small number of studies available the associa-
tion is not observable.
In a first approach we observed heterogeneity; how-
ever this variation was due to four specific studies. We
carried out a second analysis, in which the studies that
gave rise to heterogeneity were discarded. However, no
association between COMTmet and suicidal behavior
was encountered. Finally, with the aim of establishing
whether this association depended on completed suicide
or suicide attempt, we performed a last analysis which
only included suicide attempters. Once again, no asso-
ciation was confirmed.
Our study presents some limitations. Our case-control
study lacks of a specific scale investigating suicide
attempt. With regard to the meta-analysis, publication
bias has to be considered, since negative studies are less
likely to get published. Also, an overrepresentation of
the results showing an association between the poly-
morphism and the investigated disorder is also possible
[44]. Although the contribution covering from genetic
factors to personality traits may differ between male and
female subjects, we did not analyze for gender. Other
limitations are inherent in many meta-analysis of asso-
ciation (including this one) such as their retrospective
nature and the inclusion of study-level data.
Conclusion
In conclusion, our case-control study suggests no asso-
ciation between COMTmet and suicidal behavior in a
Mexican population. This same negative association was
observed in the meta-analysis. However, more compre-
hensive studies and larger samples are necessary to
determine conclusively an association of COMT with
suicidal behavior.
List of abbreviations used
COMT: catechol-o-methyl-transferase; DSM-IV: Diagnostic and statistical
manual of mental disorders-IV.
Acknowledgements
The authors gratefully acknowledge our research volunteers who helped to
recruit the participants in this study. The collection of data and the
Figure 3 Random-effects model, 95% CI and OR of each one of the studies with no heterogeneity and of the meta-analysis
comprising the studies of the met allele of the val158met polymorphism of the COMT gene and suicidal behavior.
Tovilla-Zárate et al. BMC Psychiatry 2011, 11:151
http://www.biomedcentral.com/1471-244X/11/151
Page 6 of 8genotyping of subjects were accomplished thanks to the support of grants
from the PROMEP/103.5/10/7315.
Author details
1Universidad Juárez Autónoma de Tabasco, División Académica
Multidisciplinaria de Comalcalco, Comalcalco, Tabasco, México.
2Universidad
Juárez Autónoma de Tabasco, División Académica de Ciencias de la Salud,
Villahermosa, Tabasco, México.
3Hospital de Alta Especialidad “Gustavo A.
Rovirosa P, Villahermosa, Tabasco, México.
4Hospital General de Comalcalco
Tabasco. Secretaría de Salud, Comalcalco, Tabasco, México.
5Departamento
de Genética Psiquiátrica, Instituto Nacional de Psiquiatría “Ramón de la
Fuente Muñiz”, México D. F., México.
6Servicios de Atención Psiquiátrica,
Secretaria de Salud. México D. F., México.
7Hospital General de Yajalón,
Yajalón, Chiapas, México.
Authors’ contributions
TZC and CMB conceived the study, participated in its design, and helped to
draft the manuscript. TZC, JRI, and RFT helped to perform the statistical
analysis and to draft the manuscript. VSM and PGS recruited participants,
and helped with the integration of data and analysis. GA, LL and HN
coordinated and supervised the integration of data. All authors read and
approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Received: 3 May 2011 Accepted: 21 September 2011
Published: 21 September 2011
References
1. Ono H, Shirakawa O, Nushida H, Ueno Y, Maeda K: Association between
catechol-O-methyltransferase functional polymorphism and male suicide
completers. Neuropsychopharmacology 2004, 29(7):1374-1377.
2. Arango V, Ernsberger P, Sved AF, Mann JJ: Quantitative
autoradiography of alpha 1- and alpha 2-adrenergic receptors in the
cerebral cortex of controls and suicide victims. Brain Res 1993, 630(1-
2):271-282.
3. Lester D: The concentration of neurotransmitter metabolites in the
cerebrospinal fluid of suicidal individuals: a meta-analysis.
Pharmacopsychiatry 1995, 28(2):45-50.
4. Jones JS, Stanley B, Mann JJ, Frances AJ, Guido JR, Traskman-Bendz L,
Winchel R, Brown RP, Stanley M: CSF 5-HIAA and HVA concentrations in
elderly depressed patients who attempted suicide. Am J Psychiatry 1990,
147(9):1225-1227.
5. Lee HY, Kim YK: Gender Effect of Catechol-O-Methyltransferase
Val158Met Polymorphism on Suicidal Behavior. Neuropsychobiology 2011,
63(3):177-182.
6. Savitz JB, Cupido CL, Ramesar RS: Trends in suicidology: personality as an
endophenotype for molecular genetic investigations. PLoS Med 2006,
3(5):e107.
7. Garfinkel BD, Froese A, Hood J: Suicide attempts in children and
adolescents. Am J Psychiatry 1982, 139(10):1257-1261.
8. Linkowski P, de Maertelaer V, Mendlewicz J: Suicidal behaviour in major
depressive illness. Acta Psychiatr Scand 1985, 72(3):233-238.
9. McGuffin P, Marusic A, Farmer A: What can psychiatric genetics offer
suicidology? Crisis 2001, 22(2):61-65.
10. Hawton K, Haw C, Houston K, Townsend E: Family history of suicidal
behaviour: prevalence and significance in deliberate self-harm patients.
Acta Psychiatr Scand 2002, 106(5):387-393.
11. Kia-Keating BM, Glatt SJ, Tsuang MT: Meta-analyses suggest association
between COMT, but not HTR1B, alleles, and suicidal behavior. Am J Med
Genet B Neuropsychiatr Genet 2007, 144B(8):1048-1053.
12. Baldessarini RJ, Hennen J: Genetics of suicide: an overview. Harv Rev
Psychiatry 2004, 12(1):1-13.
13. Brezo J, Klempan T, Turecki G: The genetics of suicide: a critical review of
molecular studies. Psychiatr Clin North Am 2008, 31(2):179-203.
14. Roy A, Segal NL, Centerwall BS, Robinette CD: Suicide in twins. Arch Gen
Psychiatry 1991, 48(1):29-32.
15. Schulsinger F, Kety SS, Rosenthal D, PH W: A family study of suicide. New
York, NY: Academic Press; 19791.
16. Lotta T, Vidgren J, Tilgmann C, Ulmanen I, Melen K, Julkunen I, Taskinen J:
Kinetics of human soluble and membrane-bound catechol O-
methyltransferase: a revised mechanism and description of the
thermolabile variant of the enzyme. Biochemistry 1995, 34(13):4202-4210.
17. Spielman RS, Weinshilboum RM: Genetics of red cell COMT activity:
analysis of thermal stability and family data. The American Journal of
Medical Genetics 1981, 10(3):279-290.
18. Lachman HM, Papolos DF, Saito T, Yu YM, Szumlanski CL,
Weinshilboum RM: Human catechol-O-methyltransferase
pharmacogenetics: description of a functional polymorphism and its
potential application to neuropsychiatric disorders. Pharmacogenetics
1996, 6(3):243-250.
19. Sagud M, Muck-Seler D, Mihaljevic-Peles A, Vuksan-Cusa B, Zivkovic M,
Jakovljevic M, Pivac N: Catechol-O-methyl transferase and schizophrenia.
Psychiatr Danub 2010, 22(2):270-274.
20. Hosak L: Role of the COMT gene Val158Met polymorphism in mental
disorders: a review. Eur Psychiatry 2007, 22(5):276-281.
21. Kocabas NA, Faghel C, Barreto M, Kasper S, Linotte S, Mendlewicz J,
Noro M, Oswald P, Souery D, Zohar J, Massat I: The impact of catechol-O-
methyltransferase SNPs and haplotypes on treatment response
phenotypes in major depressive disorder: a case-control association
study. Int Clin Psychopharmacol 2010, 25(4):218-227.
22. Pooley EC, Fineberg N, Harrison PJ: The met(158) allele of catechol-O-
methyltransferase (COMT) is associated with obsessive-compulsive
disorder in men: case-control study and meta-analysis. Mol Psychiatry
2007, 12(6):556-561.
23. Williams-Gray CH, Hampshire A, Barker RA, Owen AM: Attentional control
in Parkinson’s disease is dependent on COMT val 158 met genotype.
Brain 2008, 131(Pt 2):397-408.
24. De Luca V, Tharmalingam S, Muller DJ, Wong G, de Bartolomeis A,
Kennedy JL: Gene-gene interaction between MAOA and COMT in
suicidal behavior: analysis in schizophrenia. Brain Res 2006, 1097(1):26-30.
25. De Luca V, Tharmalingam S, Sicard T, Kennedy JL: Gene-gene interaction
between MAOA and COMT in suicidal behavior. Neurosci Lett 2005,
383(1-2):151-154.
26. Calati R, Porcelli S, Giegling I, Hartmann AM, Moller HJ, De Ronchi D,
Serretti A, Rujescu D: Catechol-o-methyltransferase gene modulation on
suicidal behavior and personality traits: review, meta-analysis and
association study. J Psychiatr Res 2011, 45(3):309-321.
27. Lahiri DK, Nurnberger JI Jr: A rapid non-enzymatic method for the
preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Res
1991, 19(19):5444.
28. Perroud N, Jaussent I, Guillaume S, Bellivier F, Baud P, Jollant F, Leboyer M,
Lewis CM, Malafosse A, Courtet P: COMT but not serotonin-related genes
modulates the influence of childhood abuse on anger traits. Genes Brain
Behav 2010, 9(2):193-202.
29. Perroud N, Salzmann A, Saiz PA, Baca-Garcia E, Sarchiapone M, Garcia-
Portilla MP, Carli V, Vaquero-Lorenzo C, Jaussent I, Mouthon D, Vessaz M,
Huguelet P, Courtet P, Malafosse A: Rare genotype combination of the
serotonin transporter gene associated with treatment response in
severe personality disorder. Am J Med Genet B Neuropsychiatr Genet 2010,
153B(8):1494-1497.
30. Serretti A, Chiesa A: Treatment-emergent sexual dysfunction related to
antidepressants: a meta-analysis. J Clin Psychopharmacol 2009,
29(3):259-266.
31. Tovilla-Zarate C, Camarena B, Apiquian R, Nicolini H: [Association study
and meta-analysis of the apolipoprotein gene and schizophrenia]. Gac
Med Mex 2008, 144(2):79-83.
32. Kavvoura FK, Ioannidis JP: Methods for meta-analysis in genetic
association studies: a review of their potential and pitfalls. Hum Genet
2008, 123(1):1-14.
33. Nedic G, Nikolac M, Sviglin KN, Muck-Seler D, Borovecki F, Pivac N:
Association study of a functional catechol- O-methyltransferase (COMT)
Val108/158Met polymorphism and suicide attempts in patients with
alcohol dependence. Int J Neuropsychopharmacol 2011, 14(3):377-388.
34. Russ MJ, Lachman HM, Kashdan T, Saito T, Bajmakovic-Kacila S: Analysis of
catechol-O-methyltransferase and 5-hydroxytryptamine transporter
polymorphisms in patients at risk for suicide. Psychiatry Res 2000,
93(1):73-78.
35. Zalsman G, Huang YY, Oquendo MA, Brent DA, Giner L, Haghighi F,
Burke AK, Ellis SP, Currier D, Mann JJ: No association of COMT Val158Met
Tovilla-Zárate et al. BMC Psychiatry 2011, 11:151
http://www.biomedcentral.com/1471-244X/11/151
Page 7 of 8polymorphism with suicidal behavior or CSF monoamine metabolites in
mood disorders. Arch Suicide Res 2008, 12(4):327-335.
36. Baud P, Courtet P, Perroud N, Jollant F, Buresi C, Malafosse A: Catechol-O-
methyltransferase polymorphism (COMT) in suicide attempters: a
possible gender effect on anger traits. Am J Med Genet B Neuropsychiatr
Genet 2007, 144B(8):1042-1047.
37. Nolan KA, Volavka J, Czobor P, Cseh A, Lachman H, Saito T, Tiihonen J,
Putkonen A, Hallikainen T, Kotilainen I, Rasanen P, Isohanni M, Jarvelin MR,
Karvonen MK: Suicidal behavior in patients with schizophrenia is related
to COMT polymorphism. Psychiatr Genet 2000, 10(3):117-124.
38. Rujescu D, Giegling I, Gietl A, Hartmann AM, Moller HJ: A functional single
nucleotide polymorphism (V158M) in the COMT gene is associated with
aggressive personality traits. Biol Psychiatry 2003, 54(1):34-39.
39. Liou YJ, Tsai SJ, Hong CJ, Wang YC, Lai IC: Association analysis of a
functional catechol-o-methyltransferase gene polymorphism in
schizophrenic patients in Taiwan. Neuropsychobiology 2001, 43(1):11-14.
40. Ohara K, Nagai M, Suzuki Y: Low activity allele of catechol-o-
methyltransferase gene and Japanese unipolar depression. Neuroreport
1998, 9(7):1305-1308.
41. De Luca V, Strauss J, Kennedy JL: Power based association analysis (PBAT)
of serotonergic and noradrenergic polymorphisms in bipolar patients
with suicidal behaviour. Prog Neuropsychopharmacol Biol Psychiatry 2008,
32(1):197-203.
42. Giegling I, Olgiati P, Hartmann AM, Calati R, Moller HJ, Rujescu D, Serretti A:
Personality and attempted suicide. Analysis of anger, aggression and
impulsivity. J Psychiatr Res 2009, 43(16):1262-1271.
43. Kendler KS: “A gene for...": the nature of gene action in psychiatric
disorders. Am J Psychiatry 2005, 162(7):1243-1252.
44. Van Kerkhoven LA, Laheij RJ, Jansen JB: Meta-analysis: a functional
polymorphism in the gene encoding for activity of the serotonin
transporter protein is not associated with the irritable bowel syndrome.
Aliment Pharmacol Ther 2007, 26(7):979-986.
Pre-publication history
The pre-publication history for this paper can be accessed here:
http://www.biomedcentral.com/1471-244X/11/151/prepub
doi:10.1186/1471-244X-11-151
Cite this article as: Tovilla-Zárate et al.: No association between COMT
val158met polymorphism and suicidal behavior: meta-analysis and new
data. BMC Psychiatry 2011 11:151.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Tovilla-Zárate et al. BMC Psychiatry 2011, 11:151
http://www.biomedcentral.com/1471-244X/11/151
Page 8 of 8